0
Clinical Investigations: PULMONARY FUNCTION |

Effects of Levodopa on Pulmonary Function in Parkinson’s Disease*

Bertrand Herer, MD; Isabelle Arnulf, MD; Bruno Housset, MD
Author and Funding Information

*From Service de Pneumologie (Dr. Herer), Centre Médical de Forcilles, Férolles-Attilly; Service de Pneumologie (Dr. Housset), Centre Hospitalier Intercommunal de Créteil, Créteil; and Fédération de Neurologie (Dr. Arnulf), UPRES EA 2397 Hôpital Pitié-Salpêtrière, Paris France.

Correspondence to: Bertrand Herer, MD, Centre Médical de Forcilles, F-77170 Férolles-Attilly, France; e-mail: HBherer@aol.com



Chest. 2001;119(2):387-393. doi:10.1378/chest.119.2.387
Text Size: A A A
Published online

Study objectives: Upper-airway obstruction (UAO) may be present in patients with Parkinson’s disease (PD), and its reversibility after levodopa therapy has been suggested. To investigate the effects of oral intake of levodopa on pulmonary function and UAO criteria in patients with PD, we studied 22 patients with PD.

Design: Pulmonary function tests were performed after a 12-h withdrawal of levodopa therapy, and 1 h after oral intake of placebo or levodopa, according to a double-blind, placebo-controlled, crossover study. Six UAO criteria were recorded to detect UAO in patients. UAO was found in 5 of 21 patients on baseline conditions (1 patient could not perform all tests).

Results: Among the patients with UAO, after levodopa therapy three of five patients did not meet the four of six required criteria for defining UAO. Levodopa produced its effects on UAO criteria by means of a saw-tooth pattern improvement and/or a decrease below the defined thresholds of the peak inspiratory flow and the FEV1/peak expiratory flow (PEF) and FEV1/forced expiratory flow after 50% of the FVC (FEV0.5) ratios. Levodopa PEF increased by 0.85 L/s in patients with UAO and by 0.24 L/s in patients without UAO, while after placebo it increased by 0.03 L/s in patients with UAO and decreased by 0.16 L/s in patients without UAO (p = 0.02). Whereas in patients without UAO an increase of the FEV1/PEF and FEV1/FEV0.5 ratios was observed after placebo and levodopa intake, these ratios decreased after levodopa and increased after placebo in patients with UAO.

Conclusions: These results show that levodopa administration in patients with PD induces significant variations in PEF and UAO ratios (FEV1/PEF and FEV1/FEV0.5).

Figures in this Article

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Figures

Tables

References

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Find Similar Articles
CHEST Journal Articles
PubMed Articles
Guidelines
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543